Towards Universal Access Scaling up priority HIV/AIDS interventions in the health sector Progress Report Available on http://www.who.int/hiv/pub Antiretroviral therapy for HIV infection in adults and adolescents in resourcelimited settings: Towards universal access. Recommendations for a public health approach Available on http, 2002. ,
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial, The Lancet, vol.362, issue.9387, pp.859-868, 2003. ,
DOI : 10.1016/S0140-6736(03)14341-3
A Multicenter Randomized Controlled Trial of Nevirapine Versus a Combination of Zidovudine and Lamivudine to Reduce Intrapartum and Early Postpartum Mother???to???Child Transmission of Human Immunodeficiency Virus Type 1, The Journal of Infectious Diseases, vol.187, issue.5, pp.725-735, 2003. ,
DOI : 10.1086/367898
Hepatotoxicity Associated With Nevirapine Use, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.35, issue.5, pp.538-547, 2004. ,
DOI : 10.1097/00126334-200404150-00014
Appropriate Use of Nevirapinefor Long???Term Therapy, The Journal of Infectious Diseases, vol.192, issue.3, pp.545-551, 2005. ,
DOI : 10.1086/431606
A Comprehensive Hepatic Safety Analysis of Nevirapine in Different Populations of HIV Infected Patients*, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.34, issue.1, pp.21-33, 2003. ,
DOI : 10.1097/00126334-200309011-00005
Maternal Toxicity With Continuous Nevirapine in Pregnancy, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.36, issue.3, pp.772-778, 2004. ,
DOI : 10.1097/00126334-200407010-00002
Maternal hepatotoxicity with nevirapine as part of combination antiretroviral therapy in pregnancy, HIV Medicine, vol.34, issue.4, pp.255-60, 2006. ,
DOI : 10.1097/00002030-200201250-00020
Nevirapine toxicity in a cohort of HIV-1???infected pregnant women, American Journal of Obstetrics and Gynecology, vol.194, issue.1, pp.199-202, 2006. ,
DOI : 10.1016/j.ajog.2005.05.015
Safety of nevirapine-containing antiretroviral triple therapy regimens to prevent vertical transmission in an African cohort of HIV-1-infected pregnant women, HIV Medicine, vol.92, issue.5, pp.338-382, 2006. ,
DOI : 10.1086/428093
Nevirapine-associated toxicity in HIV-infected Thai men and women, including pregnant women, HIV Medicine, vol.40, issue.2, pp.357-66, 2007. ,
DOI : 10.1097/01.aids.0000168973.59466.14
Focus on Women: Linking HIV Care and Treatment with Reproductive Health Services in the MTCT-Plus Initiative, Reproductive Health Matters, vol.365, issue.9460, pp.136-182, 2005. ,
DOI : 10.1016/S0968-8080(03)02174-8
Implementing family-focused HIV care and treatment: the first 2???years??? experience of the mother-to-child transmission -plus program in Abidjan, C??te d???Ivoire, Tropical Medicine & International Health, vol.4, issue.2, pp.204-216, 2009. ,
DOI : 10.1111/j.1365-3156.2008.02182.x
Essential of Medical statistics, 2003. ,
Haematological changes in adults receiving a zidovudine-containing HAART regimen in combination with cotrimoxazole in Cote d'Ivoire, Antivir Ther, vol.10, issue.5, pp.615-639, 2005. ,
CF; DART Trial Team. Prevalence, incidence and predictors of severe anaemia with zidovudinecontaining regimens in African adults with HIV infection within the DART trial, Gilks ,
Clinical Toxicity of Highly Active Antiretroviral Therapy in a Home-Based AIDS Care Program in Rural Uganda, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.44, issue.4, pp.456-62, 2007. ,
DOI : 10.1097/QAI.0b013e318033ffa1
Sex Differences in Nevirapine Rash, Clinical Infectious Diseases, vol.32, issue.1, pp.124-133, 2001. ,
DOI : 10.1086/317536
Drug-Induced Liver Injury Associated with the Use of Nonnucleoside Reverse-Transcriptase Inhibitors, Clinical Infectious Diseases, vol.38, issue.Supplement 2, 2004. ,
DOI : 10.1086/381450
Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: Role of hepatitis C and B infections, Hepatology, vol.284, issue.1, pp.182-191, 2002. ,
DOI : 10.1053/jhep.2002.30319
Ethnic or Racial Differences Revisited, Clinical Pharmacokinetics, vol.19, issue.5, pp.957-64, 2006. ,
DOI : 10.2165/00003088-200645100-00001
ART-CC) groups. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and highincome countries, Lancet, vol.367, issue.9513, pp.817-841, 2006. ,
Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study, AIDS, vol.20, issue.8, pp.1181-1190, 2006. ,
DOI : 10.1097/01.aids.0000226959.87471.01
Variation of CD4 Count and Percentage during Pregnancy and after Delivery: Implications for HAART Initiation in Resource-Limited Settings, AIDS Research and Human Retroviruses, vol.23, issue.12, pp.1469-74, 2007. ,
DOI : 10.1089/aid.2007.0059
URL : https://hal.archives-ouvertes.fr/inserm-00201770